Holen Sie sich die Stockscreener-App
4.91
3.37%
0.16
Optimizerx Corp Aktie (OPRX) Neueste Nachrichten
OptimizeRx Co. (NASDAQ:OPRX) Stake Increased by BNP Paribas Financial Markets - Defense World
The Analyst Verdict: OptimizeRx In The Eyes Of 6 Experts - Benzinga
OptimizeRx (NASDAQ:OPRX) Earns Equal Weight Rating from Analysts at Stephens - MarketBeat
OptimizeRx's SWOT analysis: digital health stock faces growth hurdles By Investing.com - Investing.com Canada
OptimizeRx's SWOT analysis: digital health stock faces growth hurdles - Investing.com
OptimizeRx Co. (NASDAQ:OPRX) CEO William J. Febbo Purchases 20,000 Shares - MarketBeat
OptimizeRx CEO William Febbo acquires $100,220 in company shares - Investing.com
OptimizeRx CEO William Febbo acquires $100,220 in company shares By Investing.com - Investing.com UK
OptimizeRx's SWOT analysis: digital health firm's stock faces growth hurdles - Investing.com
AWM Investment Company, Inc. Reduces Stake in OptimizeRx Corp - GuruFocus.com
Quest Partners LLC Buys 9,739 Shares of OptimizeRx Co. (NASDAQ:OPRX) - Defense World
US Penny Stocks To Watch In November 2024 - Simply Wall St
OptimizeRx (OPRX) Surges 19.8%: Is This an Indication of Further Gains? - MSN
OptimizeRx to Participate in Upcoming Investor Conferences - The Manila Times
OptimizeRx to Present at ROTH and Canaccord Genuity Healthcare Conferences in NYC | OPRX Stock News - StockTitan
Janney Montgomery Scott LLC Buys Shares of 104,917 OptimizeRx Co. (NASDAQ:OPRX) - Defense World
Brokerages Set OptimizeRx Co. (NASDAQ:OPRX) Price Target at $11.58 - Defense World
OptimizeRx Corporation (NASDAQ:OPRX) Q3 2024 Earnings Call Transcript - Insider Monkey
AWM Investment Company's Strategic Acquisition of OptimizeRx Cor - GuruFocus.com
Divisadero Street Capital Management's Strategic Acquisition of OptimizeRx Shares - GuruFocus.com
OptimizeRX shares target cut, maintains buy rating on lower revenue - Investing.com
OptimizeRx's (OPRX) "Buy" Rating Reiterated at Roth Mkm - MarketBeat
Optimizerx stock hits 52-week low at $4.69 amid market challenges - Investing.com Nigeria
Earnings call: OptimizeRx reports 30% revenue growth in Q3 By Investing.com - Investing.com UK
OptimizeRx (NASDAQ:OPRX) Price Target Cut to $8.00 by Analysts at Stifel Nicolaus - MarketBeat
JMP Securities Lowers OptimizeRx (NASDAQ:OPRX) Price Target to $8.00 - MarketBeat
OptimizeRx (NASDAQ:OPRX) Given New $5.00 Price Target at Barclays - MarketBeat
OptimizeRx Corp. (OPRX) Surpasses Q3 Earnings Estimates - MSN
OptimizeRx Reports Third Quarter 2024 Financial Results - The Manila Times
OptimizeRx Corp (OPRX) Q3 2024 Earnings Call Highlights: Revenue Surge and Strategic Shifts ... By GuruFocus - Investing.com Canada
Earnings call: OptimizeRx reports 30% revenue growth in Q3 - Investing.com India
OPTIMIZERx earnings beat by $0.06, revenue fell short of estimates - Investing.com
OptimizeRx Q3 Revenue Jumps 30% to $21.3M, Updates 2024 Guidance | OPRX Stock News - StockTitan
OptimizeRx (OPRX) Scheduled to Post Earnings on Wednesday - Defense World
OptimizeRx (OPRX) Set to Announce Quarterly Earnings on Wednesday - Defense World
OptimizeRx (OPRX) to Release Quarterly Earnings on Wednesday - MarketBeat
Rice Hall James & Associates LLC Boosts Holdings in OptimizeRx Co. (NASDAQ:OPRX) - MarketBeat
OptimizRx stock hits 52-week low at $5.42 amid market challenges - Investing.com India
OptimizeRx Sets Third Quarter 2024 Conference Call for November 13, 2024 at 4:30 p.m. ET - The Manila Times
Optimizerx stock hits 52-week low at $6.29 amid market shifts - Investing.com
Squarepoint Ops LLC Takes Position in OptimizeRx Co. (NASDAQ:OPRX) - Defense World
OptimizeRx Co. (NASDAQ:OPRX) Shares Bought by Renaissance Technologies LLC - Defense World
American Century Companies Inc. Lowers Stake in OptimizeRx Co. (NASDAQ:OPRX) - Defense World
OptimizeRx (OPRX) Moves 5.4% Higher: Will This Strength Last? - Yahoo Finance
Optimizerx stock hits 52-week low at $6.92 amid market shifts By Investing.com - Investing.com South Africa
Optimizerx stock hits 52-week low at $6.92 amid market shifts - Investing.com Australia
OptimizeRx's SWOT analysis: digital health firm faces growth challenges By Investing.com - Investing.com UK
OptimizeRx's SWOT analysis: digital health firm faces growth challenges - Investing.com
Rhumbline Advisers Increases Stock Holdings in OptimizeRx Co. (NASDAQ:OPRX) - Defense World
OptimizeRx Co. (NASDAQ:OPRX) Shares Bought by Bank of New York Mellon Corp - Defense World
Divisadero Street Capital Management LP Lowers Stake in OptimizeRx Co. (NASDAQ:OPRX) - Defense World
OptimizeRx Co. (NASDAQ:OPRX) Shares Acquired by Rice Hall James & Associates LLC - MarketBeat
OptimizeRx expands pharma client engagement to $10M - Investing.com
OptimizeRx Continues to Expand its Strategic Relationship with a Top-Tier Pharma Client via a Multi-Brand, Multi-Solution Investment Commitment with Over $10M In-Year Total Value - The Tech Outlook
1.16%
0.30%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):